BioTuesdays

Tag - H.C. Wainwright

CareDx Logo
Markets

HCW cuts CareDx to neutral but ups PT to $15

H.C. Wainwright downgraded CareDx (NASDAQ:CDNA) to “neutral” from “buy” but raised its price target to $15 from $14, citing the company’s valuation. The stock closed at $15.78 on June 18. Earlier this month, CareDx held...

June 19, 2018
Tocagen Logo
Markets

HCW starts Tocagen at buy; PT $14.50

H.C. Wainwright initiated coverage of Tocagen (NASDAQ:TOCA) with a “buy” rating and price target of $14.50. The stock closed at $9.64 on June 8. Analyst Swayampakula Ramakanth writes that the company’s lead product...

June 11, 2018